GENE ONLINE|News &
Opinion
Blog

Migraine
Neurolief’s Neuromodulation Device Receives Japanese Approval for At-Home Migraine Treatment
2024-01-16
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Daiichi Sankyo Partners with Lilly on a Second Migraine Drug Deal in Japan
2021-09-01
Spotlight: The Revitalization of Chronic Migraine Therapies
2020-09-02
Ubrelvy Approval, the Best New Year Gift for CGRP Migraine Victims
2020-01-09
Weekly Top 5 in China (0210-0216)
2019-02-18
Clash of three migraines medications & cost benefit for patients
2018-10-01
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top